The medical diagnostic company BioPorto has recently announced that it will be introducing Christopher Bird as the new Chief Medical Officer.
Bird joins BioPorto from his role at Roche Diagnostics as Head of Medical and Scientific Affairs in North America. After over 10 years with this medical and scientific affairs organisation, Christopher will now be responsible for leading the development of diagnostic products at BioPorto.
Image Credit: Proactive Investors